Brainsway Stock Current Valuation
| BWAY Stock | ILA 1,746 43.00 2.52% |
Valuation analysis of Brainsway helps investors to measure Brainsway's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Brainsway's price fluctuation is very steady at this time. Calculation of the real value of Brainsway is based on 3 months time horizon. Increasing Brainsway's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Brainsway is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brainsway Stock. However, Brainsway's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1746.0 | Real 1448.58 | Hype 1746.0 |
The real value of Brainsway Stock, also known as its intrinsic value, is the underlying worth of Brainsway Company, which is reflected in its stock price. It is based on Brainsway's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Brainsway's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Brainsway helps investors to forecast how Brainsway stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brainsway more accurately as focusing exclusively on Brainsway's fundamentals will not take into account other important factors: Brainsway Company Current Valuation Analysis
Brainsway's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Brainsway Current Valuation | (85.93 M) |
Most of Brainsway's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Brainsway is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Brainsway has a Current Valuation of (85.93 Million). This is 100.6% lower than that of the Healthcare sector and 100.69% lower than that of the Medical Devices industry. The current valuation for all Israel stocks is 100.52% higher than that of the company.
Brainsway Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Brainsway's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Brainsway could also be used in its relative valuation, which is a method of valuing Brainsway by comparing valuation metrics of similar companies.Brainsway is currently under evaluation in current valuation category among its peers.
Brainsway Fundamentals
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0751 | |||
| Profit Margin | (0.37) % | |||
| Operating Margin | (0.29) % | |||
| Current Valuation | (85.93 M) | |||
| Shares Outstanding | 33.08 M | |||
| Shares Owned By Insiders | 19.83 % | |||
| Shares Owned By Institutions | 1.11 % | |||
| Price To Book | 0.65 X | |||
| Price To Sales | 3.76 X | |||
| Revenue | 29.66 M | |||
| Gross Profit | 24.35 M | |||
| EBITDA | (3.31 M) | |||
| Net Income | (6.46 M) | |||
| Cash And Equivalents | 55.87 M | |||
| Cash Per Share | 1.73 X | |||
| Total Debt | 672 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 9.26 X | |||
| Book Value Per Share | 1.46 X | |||
| Cash Flow From Operations | 884 K | |||
| Earnings Per Share | (0.22) X | |||
| Target Price | 14.0 | |||
| Number Of Employees | 118 | |||
| Beta | 0.2 | |||
| Market Capitalization | 116.06 M | |||
| Total Asset | 75.73 M | |||
| Net Asset | 75.73 M |
About Brainsway Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Brainsway's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainsway using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainsway based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Brainsway Stock
When determining whether Brainsway offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainsway's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainsway. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Brainsway Stock refer to our How to Trade Brainsway Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.